Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford team who have developed a COVID-19 vaccine in record time have been shortlisted for the Excellence in Healthcare Award at the NHS Parliamentary Awards.

Scientists analyzing covid 19 sample with microscope and holding covid 19 blood sample tube

The team from the Oxford Vaccine Group and Jenner Institute were nominated by Layla Moran, MP for Oxford West and Abingdon, and won the regional Excellence in Healthcare award.

The news coincided with announcement of interim data from phase III of the vaccine trial, which showed that the Oxford candidate vaccine was effective at preventing COVID-19 and offered a high level of protection. One dosing regimen indicated that the vaccine is 90 percent effective.

Layla Moran said:

"I'm absolutely delighted. There were nearly 700 nominations by MPs this year, so to be shortlisted is a huge achievement - the vaccine team really deserve it!

"The Oxford Vaccine Group and the Jenner Institute have been working so incredibly hard since the beginning of the pandemic to produce a vaccine that will be life changing for so many people around the world."

The NHS Parliamentary Awards are an annual opportunity to recognise and appreciate the very best about our local healthcare service.

The full story is available on the Oxford University Hospitals website

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.